The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
DOI:
https://doi.org/10.3889/oamjms.2016.060Keywords:
severe COPD, very severe COPD, comorbidity, prevalence of diabetes mellitus type 2Abstract
AIM: The aim of the study was to investigate the prevalence of diabetes mellitus in privies diagnosed chronic obstructive pulmonary disease (COPD) patients with severe and very severe disease, which ware stable.
METHODS: We investigated 100 subjects, all of them smokers, with smoking status >10 years. They were stratified in two groups. It was clinical, randomized, cross sectional study. Besides demographic parameters, functional parameters, BMI, cholesterol, LDL and HDL, and the level of blood sugar was measured.
RESULTS: The prevalence of diabetes mellitus in our survey in total number of COPD patients with severe and very severe stage was 21%. In the very severe group were recorded significantly higher average values of glycaemia compared with severe group (7.67 ± 3.7 vs. 5.62 ± 0.9, p = 0.018). In the group with severe COPD, it was not confirmed any factor with significant predictive effect on the values of glycaemia. As independent significant factors that affect blood glucose in a group of very severe COPD were confirmed cholesterol (p <0.0001) and HDL (p = 0.018).
CONCLUSION: These results suggest that the presence of the COPD in patients itself is a factor that results in the clinical presentation of diabetes mellitus Type 2.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. [Last accessed on 2013 Feb 15]. www.goldcopd.org
Mathers D, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine. 2006;3(11):e442. http://dx.doi.org/10.1371/journal.pmed.0030442 PMid:17132052 PMCid:PMC1664601
Barnes P. Chronic Obstructive Pulmonary Disease. N Engl J Med. 2000; 343:269-280. http://dx.doi.org/10.1056/NEJM200007273430407 PMid:10911010
Manzotti E, Barclay L, Patel A, Hurst J. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med. 2011; 5(5), 647–662. http://dx.doi.org/10.1586/ers.11.62 PMid:21955235
Barnes P. Chronic Obstructive Pulmonary Disease. N Engl J Med. 2000; 343:269-280. http://dx.doi.org/10.1056/NEJM200007273430407 PMid:10911010
Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220. http://dx.doi.org/10.1371/journal.pmed.1000220 PMid:20305715 PMCid:PMC2838746
Chatila W, Thomashow B, Minai O, Criner G, Make B. Comorbidities in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc. 2008; 5(4): 549–555. http://dx.doi.org/10.1513/pats.200709-148ET PMid:18453370 PMCid:PMC2645334
Naik D, Joshi A, Vizhalil Paul V,Thomas N. Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat. Indian J Endocrinol Metab. 2014;18(5): 608–616. PMid:25285275 PMCid:PMC4171881
Young J, Sin D. Lung inflammation in COPD: why does it matter? F1000 Med Rep. 2012; 4: 23.
Maumus S, Marie B, Siest G. PHARMD, Visvikis-Siest S. A Prospective Study on the Prevalence of Metabolic Syndrome Among Healthy French Families Two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-α) are revealed in the offspring of parents with metabolic syndrome. Diabetes Care. 2005; 28 (3): 675-682. http://dx.doi.org/10.2337/diacare.28.3.675 PMid:15735207
Breyer K, Spruit A, Hanson K, Franssen M, Vanfleteren E, Groenen T, Bruijnzeel L, Wouters F, Rutten P. Prevalence of metabolic syndrome in COPD patients and its consequences. PLoS One. 2014 Jun 20;9(6):e98013. http://dx.doi.org/10.1371/journal.pone.0098013 PMid:24950070 PMCid:PMC4064974
Mahishale V, Mahishale A, Patil B, Sindhuri A, Eti A. Screening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in India. Niger Med J. 2015; 56(2): 122–125. http://dx.doi.org/10.4103/0300-1652.150699 PMid:25838628 PMCid:PMC4382602
Phillips C. Nutrigenetics and Metabolic Disease: Current Status and Implications for Personalised Nutrition Nutrients. 2013 Jan; 5(1): 32–57. http://dx.doi.org/10.1201/b16307-3
International Diabetes Federation and data from the National Registry of diabetes. Official Gazette of Republic of Macedonia. 43/2012 and 145/2012.
Rogliani P, Lucà G, Lauro D. Chronic obstructive pulmonary disease and diabetes. COPD Research and Practice. 2015;1:3. http://dx.doi.org/10.1186/s40749-015-0005-y
Kinney G, Baker E. Type 2 diabetes mellitus and chronic obstructive pulmonary disease: need for a double-pronged approach. 2014; 4(4), 307–310.
Barnes P, Celli B. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009. 33(5):1165-1185. http://dx.doi.org/10.1183/09031936.00128008 PMid:19407051
Mirrakhimov M. Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. CardiovascDiabetol. 2012; 11: 132. http://dx.doi.org/10.1186/1475-2840-11-132
Kaur J. A Comprehensive Review on Metabolic Syndrome. Cardiology Research and Practice, Review Article. 2014 (2014), Article ID 943162.
Rimm B, Manson E, Stampfer J, Colditz A, Willett C, Rosner B, et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health. 1993;83:211–4. http://dx.doi.org/10.2105/AJPH.83.2.211 PMid:8427325 PMCid:PMC1694562
Cavaillès A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–75. http://dx.doi.org/10.1183/09059180.00008612 PMid:24293462
Mahishale V, Mahishale A, Patil B, Sindhuri A, Et A. Screening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in India. Niger Med J. 2015; 56(2): 122–125. http://dx.doi.org/10.4103/0300-1652.150699 PMid:25838628 PMCid:PMC4382602
Hansell L, Walk A, et al. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis.EurRespir J. 2003;22:809–14. http://dx.doi.org/10.1183/09031936.03.00031403
Directorate General of Health Services, India. National programme for prevention and control of cancer, diabetes, cardiovascular disease and stroke (NPCDCS) [Last accessed on 2013 Mar 10]. Available from: http://health.bih.nic.in/Docs/Guidelines-NPCDCS.pdf
Rana S, Mittleman A, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care.2004; 27(10):2478. http://dx.doi.org/10.2337/diacare.27.10.2478 PMid:15451919
Mannino M, Thorn D, Swensen A, Hulguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962–9. http://dx.doi.org/10.1183/09031936.00012408 PMid:18579551
Kiran K, Majeed N, Zuberi B. Comparison of frequency of insulin resistance in patients with chronic obstructive pulmonary disease with normal controls. Pak J Med Sci. 2015; 31(6): 1506–1510. http://dx.doi.org/10.12669/pjms.316.7983 PMid:26870125 PMCid:PMC4744310
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0